143 related articles for article (PubMed ID: 34186090)
1. Adjuvant Chemotherapy for High-risk Pathologic Stage I Non-Small Cell Lung Cancer.
Tsutani Y; Imai K; Ito H; Miyata Y; Ikeda N; Nakayama H; Okada M
Ann Thorac Surg; 2022 May; 113(5):1608-1616. PubMed ID: 34186090
[TBL] [Abstract][Full Text] [Related]
2. Propensity score-matched analysis of adjuvant chemotherapy for stage I non-small cell lung cancer.
Tsutani Y; Miyata Y; Kushitani K; Takeshima Y; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1179-85. PubMed ID: 25112928
[TBL] [Abstract][Full Text] [Related]
3. The role of adjuvant chemotherapy in resected stage I non - small cell lung cancer: A Turkish Oncology Group Study.
Ak N; Ozkan B; Yenigun MB; Yilmazbayhan D; Toker A; Ferhatoglu F; Yasar A; Dizbay Sak S; Tanju S; Dilege S; Erus S; Bulutay P; Firat P; Molinas Mandel N; Kilickap S; Onder S; Dikmen E; Alan O; Yumuk PF; Bozkurtlar E; Lacin T; Yildizeli B; Ozturk A; Kocaturk C; Karapinar K; Urer N; Oyan B; Aydiner A; Demirkazik A; Eralp Y
J BUON; 2021; 26(3):819-829. PubMed ID: 34268941
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
Kim IH; Lee IH; Lee JE; Hong SH; Kim TJ; Lee KY; Kim YK; Kim SJ; Sung SW; Park JK; Yoo IR; Kim YS; Kim JO; Kang JH
Clin Lung Cancer; 2016 Sep; 17(5):e31-e43. PubMed ID: 26992846
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy for visceral pleural invasion in 3-4-cm non-small-cell lung cancer improves survival.
Wightman SC; Lee JY; Ding L; Atay SM; Shemanski KA; McFadden PM; David EA; Kim AW
Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35325098
[TBL] [Abstract][Full Text] [Related]
6. Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy.
Merritt RE; Abdel-Rasoul M; Fitzgerald M; D'Souza DM; Kneuertz PJ
Clin Lung Cancer; 2021 Jul; 22(4):e574-e583. PubMed ID: 33234491
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.
Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
Eur J Cardiothorac Surg; 2013 Sep; 44(3):e200-6. PubMed ID: 23766428
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.
Wang S; Xu J; Wang R; Qian F; Yang W; Qiao R; Zhang B; Qian J; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Nov; 156(5):2006-2015.e2. PubMed ID: 30104070
[TBL] [Abstract][Full Text] [Related]
10. Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non-Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features.
Pathak R; Goldberg SB; Canavan M; Herrin J; Hoag JR; Salazar MC; Papageorge M; Ermer T; Boffa DJ
JAMA Oncol; 2020 Nov; 6(11):1741-1750. PubMed ID: 32940636
[TBL] [Abstract][Full Text] [Related]
11. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
[TBL] [Abstract][Full Text] [Related]
12. The impact of epidermal growth factor receptor mutation status on adjuvant chemotherapy for patients with high-risk stage I lung adenocarcinoma.
Tsutani Y; Ito M; Shimada Y; Ito H; Ikeda N; Nakayama H; Okada M
J Thorac Cardiovasc Surg; 2022 Nov; 164(5):1306-1315.e4. PubMed ID: 35181001
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy.
Qian J; Xu J; Wang S; Qian F; Yang W; Zhang B; Zhang Y; Nie W; Lou Y; Lu J; Zhang X; Zhang W; Chu T; Zhong H; Fang W; Zhao H; Han B
Ann Surg Oncol; 2019 Aug; 26(8):2392-2400. PubMed ID: 31011907
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
[TBL] [Abstract][Full Text] [Related]
16. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.
Oven Ustaalioglu BB; Unal OU; Turan N; Bilici A; Kaya S; Eren T; Ulas A; Inal A; Berk V; Demirci U; Alici S; Bal O; Benekli M; Gumus M
Asian Pac J Cancer Prev; 2013; 14(11):6287-92. PubMed ID: 24377519
[TBL] [Abstract][Full Text] [Related]
18. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
Moon Y; Lee KY; Park JK
World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
[TBL] [Abstract][Full Text] [Related]
19. Value of adjuvant chemotherapy for patients with pT2N0M0 non-small cell lung cancer receiving radical resection.
Chen S; Yang S; Zhao Y; Zhang Y; Huang Q; Wu H; Hu H; Sun Y; Zhang Y; Xiang J; Ye T; Chen H
Thorac Cancer; 2024 Jan; 15(3):258-265. PubMed ID: 38098268
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Factors of Pathological N1 Non-small Cell Lung Cancer After Curative Resection Without Adjuvant Chemotherapy.
Moon Y; Sung SW; Park JK; Lee KY; Ahn S
World J Surg; 2019 Apr; 43(4):1162-1172. PubMed ID: 30536021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
